MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus

NCT04810507 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Anagliptin BID Treatment

Sponsor

JW Pharmaceutical